Vanguard Global Advisers »

Eikon Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Eikon Therapeutics (EIKN) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $145k 14k 10.58

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Eikon Therapeutics

FMR
BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
Alliancebernstein
Vanguard Capital Management
EcoR1 Capital
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board
Franklin Resources
Citadel Advisors

View all funds holding Eikon Therapeutics